Support provided by educational grants from the following companies:
Introduction/Activity Overview Statement of Need
To ensure consistent, high quality, evidence-based patient care, the AUA has released a Clinical Practice Guideline on the Detection of Prostate Cancer at the 2013 AUA Annual Meeting. With the release of a new clinical guideline, urologists need up-to-date education regarding targeted screening and how to counsel patients about their prostate cancer risk. In a survey conducted by the Institute for Health System Change, 73 percent of clinicians reported not knowing where to find specific treatment guidelines.3 This activity includes the presentations of six prostate cancer courses recorded live at the 2013 AUA Annual Meeting in San Diego, California.
3Institute for Health System Change 12,000 physician survey, 2004.
After participating in this activity, the learner should be able to describe recent developments in the medical and surgical management of prostate cancer patients.
This enduring material is designed for urologists.
To claim CME credit/hours of participation for the webcast, the learner must view the webcast, complete the posttest, passing with 80% accuracy and submit the evaluation.
All data concerning results of the study program are strictly confidential and security measures have been set up at the AUAER to ensure that only the individual participant has access to his/her scores.
Estimated time to complete this activity
Minimum Hardware and Software Requirements
As a provider accredited by the ACCME, the AUAER must ensure balance, independence, objectivity and scientific rigor in all its activities.
All persons in a position to control the content of an educational activity (i.e., activity planners and presenters) provided by the AUAER are required to disclose to the provider any relevant financial relationships they have with any commercial interest. The AUAER must determine if an individual's financial relationships may influence the educational content with regard to exposition or conclusion, and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from serving as planners or presenters, but rather to provide the audience with information on which they can make informed judgments about the material presented.
Click on each presentation to view faculty/authors' disclosures
|Gopal Badlani, MD||Lithotripsy Group: Piedmont Stone & Physician Discovery||Investment Interest||Yes|
|Elspeth McDougall, MD||Nothing to Disclose|
|Sheila Stark, PhD||Nothing to Disclose|
|Kim Haslam||Nothing to Disclose|
|Candice Binuyo||Nothing to Disclose|
The American Urological Association Education and Research, Inc (AUAER) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Urological Association Education and Research, Inc designate this enduring material for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AUAER takes responsibility for the content, quality, and scientific integrity of this CME activity.
©American Urological Association, 2013
The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
Resolution of Identified Conflict of Interest
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
Evidence Based Content
As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUA to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
Off-label or Unapproved Use of Drugs or Devices
It is the policy of the AUAER to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the product prescribing information for full disclosure of approved uses.
AUA Privacy and Confidentiality Policy
For all inquiries regarding CME credit please email: